SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Wednesday, May 20, 2026, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the first quarter ended March 31, 2026.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
